LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for ALX Oncology and Millions of Other Companies

Sign up for full access to ALX Oncology information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Loading spinner
Gathering insights about ALX Oncology…

Similar companies to ALX Oncology

✕

Access Insights for ALX Oncology and Millions of Other Companies

Sign up for full access to ALX Oncology information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

ALX Oncology Tech Stack

ALX Oncology uses 8 technology products and services including Microsoft Outlook, Microsoft, RSS, and more. Explore ALX Oncology's tech stack below.

  • Microsoft Outlook
    Email
  • Microsoft
    Miscellaneous
  • RSS
    Miscellaneous
  • Acquia Cloud Platform
    Platform As A Service
  • PHP
    Programming Languages
  • X-XSS-Protection
    Security
  • HSTS
    Security
  • Akamai Web Application Protector
    Security

Media & News

ALX Oncology's Email Address Formats

ALX Oncology uses at least 1 format(s):
ALX Oncology Email FormatsExamplePercentage
FLast@alxoncology.comJDoe@alxoncology.com
72%
First@alxoncology.comJohn@alxoncology.com
19%
Last@alxoncology.comDoe@alxoncology.com
6%
First.Last@alxoncology.comJohn.Doe@alxoncology.com
3%

Frequently Asked Questions

Where is ALX Oncology's headquarters located?

Minus sign iconPlus sign iconALX Oncology's main headquarters is located at 323 Allerton Ave South San Francisco, California 94080 US. The company has employees across 4 continents, including North AmericaAfricaAsia.

What is ALX Oncology's stock symbol?

Minus sign iconPlus sign iconALX Oncology is a publicly traded company; the company's stock symbol is ALXO.

What is ALX Oncology's official website and social media links?

Minus sign iconPlus sign iconALX Oncology's official website is alxoncology.com and has social profiles on LinkedIn.

How much revenue does ALX Oncology generate?

Minus sign iconPlus sign icon As of October 2024, ALX Oncology's annual revenue reached $7.5M.

What is ALX Oncology's SIC code NAICS code?

Minus sign iconPlus sign iconALX Oncology's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does ALX Oncology have currently?

Minus sign iconPlus sign iconAs of October 2024, ALX Oncology has approximately 88 employees across 4 continents, including North AmericaAfricaAsia. Key team members include Chief Executive Officer: J. L.Chief Financial Officer: P. G.Chief Medical Officer: S. R.. Explore ALX Oncology's employee directory with LeadIQ.

What industry does ALX Oncology belong to?

Minus sign iconPlus sign iconALX Oncology operates in the Biotechnology Research industry.

What technology does ALX Oncology use?

Minus sign iconPlus sign iconALX Oncology's tech stack includes Microsoft OutlookMicrosoftRSSAcquia Cloud PlatformPHPX-XSS-ProtectionHSTSAkamai Web Application Protector.

What is ALX Oncology's email format?

Minus sign iconPlus sign iconALX Oncology's email format typically follows the pattern of . Find more ALX Oncology email formats with LeadIQ.

How much funding has ALX Oncology raised to date?

Minus sign iconPlus sign icon As of October 2024, ALX Oncology has raised $63M in funding. The last funding round occurred on Oct 05, 2023 for $63M.

When was ALX Oncology founded?

Minus sign iconPlus sign iconALX Oncology was founded in 2015.
ALX Oncology

ALX Oncology

Biotechnology ResearchCalifornia, United States51-200 Employees

ALX Oncology is a publicly traded, clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system. ALX Oncology’s lead product candidate, evorpacept (also known as ALX148), is a next generation CD47 blocking therapeutic that combines a high-affinity CD47 binding domain with an inactivated, proprietary Fc domain. Evorpacept has demonstrated promising clinical responses across a range of hematologic and solid malignancies in combination with a number of leading anti-cancer agents.

✕

Access Insights for ALX Oncology and Millions of Other Companies

Sign up for full access to ALX Oncology information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
323 Allerton Ave South San Francisco, California 94080 US
Website
alxoncology.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
ALXO
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $63M

    ALX Oncology has raised a total of $63M of funding over 6 rounds. Their latest funding round was raised on Oct 05, 2023 in the amount of $63M.

  • $10M

    ALX Oncology's revenue is in the range of $10M

Section iconFunding & Financials

  • $63M

    ALX Oncology has raised a total of $63M of funding over 6 rounds. Their latest funding round was raised on Oct 05, 2023 in the amount of $63M.

  • $10M

    ALX Oncology's revenue is in the range of $10M

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for ALX Oncology and Millions of Other Companies

Sign up for full access to ALX Oncology information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.